Leading the way for myopia management, EssilorLuxottica continues to invest in research and development to provide the best solutions as well as drive action by raising awareness and advancing education with key global partners.

Every year Myopia Awareness Week, held May 13-19 and championed by the Brien Holden Vision Institute (BHVI), provides an important opportunity to take action for myopia management.

As always, EssilorLuxottica remains dedicated to helping fight myopia by driving innovation, raising awareness, building key partnerships and sharing the latest evidence-based insights on myopia and Essilor Stellest lenses* with eyecare professionals.

Highlights From Myopia Awareness Week 2024

Leonardo: To kick off Myopia Awareness Week, a live Leonardo session – entitled “Myopia Management: Way Forward” – was moderated by Olga Prenat, Head of Medical & Professional Affairs at EssilorLuxottica and Global Myopia Awareness Coalition Board Chair, and welcomed experts from global partner organizations, the International Myopia Institute and the World Society of Paediatric Ophthalmology and Strabismus (WSPOS) to discuss moving from myopia correction to myopia management as a standard of care. View the replay now.

Essilor Stellest Lenses with Sun Tints & Extended Range: Essilor Stellest lenses are now available with sun tints, providing children and teenagers with the added benefit of UV protection during outdoor activities. The lenses come in several vibrant colors and give a greater pairing choice when choosing frames. In addition, Essilor Stellest clear spectacle lenses for myopia management will be available in a wider prescription range globally to meet the needs of more myopic children and teenagers.

Driving the Global Conversation With Key Partners at ARVO and EAOO: Helping drive the global conversation on myopia, EssilorLuxottica participated in the ARVO (Association for Research in Vision and Ophthalmology) annual meeting, where EssilorLuxottica’s R&D team presented the latest research and insights on myopia management as well as the five-year clinical study results for Essilor Stellest lenses, which demonstrate continued long-term efficacy for controlling myopia progression.
Along with education sessions from its experts, the Company also showcased its Digital Infinite Refraction range consisting of Vision-R 800, Vision-S 700 and its specialized biometer, the Myopia Expert 700, designed to monitor myopia progression.
EssilorLuxottica also continued its long-standing partnership with the European Academy of Optometry and Optics (EAOO) by taking part in its 15th annual conference in Finland, giving updates on Essilor Stellest lenses, and discussing new approaches and advances in clinical refraction.

Coming up, EssilorLuxottica will present new insights on myopia management at the World Congress of Paediatric Ophthalmology and Strabismus in July in Malaysia followed by the International Myopia Conference, which is the largest global scientific gathering on myopia, in September in China.

Also, stay tuned for new sponsored content with its partners, such as Myopia Profile, on key topics including Essilor Stellest lenses in the coming months!

_{*Essilor Stellest lenses are not currently FDA approved and are not commercially available for sale in all countries, including the U.S.}